We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$236M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$31.2M
3
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
+$25M
4
AMAT icon
Applied Materials
AMAT
+$22.1M
5
BAX icon
Baxter International
BAX
+$20.4M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSIBU
751
DELISTED
Tishman Speyer Innovation Corp. II Unit
TSIBU
$200K ﹤0.01%
20,000
– –
IACB.U
752
DELISTED
ION Acquisition Corp 2 Ltd. Units, each consisting of one Class A ordinary share and one-eighth of o
IACB.U
$200K ﹤0.01%
20,000
– –
CSTA.U
753
DELISTED
Constellation Acquisition Corp I Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CSTA.U
$199K ﹤0.01%
20,000
– –
GIIXU
754
DELISTED
Gores Holdings VIII, Inc. Unit
GIIXU
$199K ﹤0.01%
20,000
– –
HUGS.U
755
DELISTED
USHG Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-third of one Warrant
HUGS.U
$199K ﹤0.01%
20,000
– –
FRXB.U
756
DELISTED
Forest Road Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
FRXB.U
$198K ﹤0.01%
20,000
– –
WPCB.U
757
DELISTED
Warburg Pincus Capital Corporation I-B Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCB.U
$198K ﹤0.01%
20,000
– –
COLIU
758
DELISTED
Colicity Inc. Units
COLIU
$198K ﹤0.01%
20,000
– –
KVSA
759
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$197K ﹤0.01%
20,000
– –
NSTD.U
760
DELISTED
Northern Star Investment Corp. IV Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTD.U
$197K ﹤0.01%
20,000
– –
NSTC.U
761
DELISTED
Northern Star Investment Corp. III Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTC.U
$197K ﹤0.01%
20,000
– –
HYACU
762
DELISTED
Haymaker Acquisition Corp. III Unit
HYACU
$182K ﹤0.01%
18,326
– –
NGC.U
763
DELISTED
Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant
NGC.U
$181K ﹤0.01%
18,129
– –
XGN icon
764
Exagen
XGN
$108M
$160K ﹤0.01%
11,768
-15,373
-57% -$204K
DSAQ.U
765
DELISTED
Direct Selling Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of redeemable warrant
DSAQ.U
$151K ﹤0.01%
+15,000
New +$151K
FSRXU
766
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
$148K ﹤0.01%
15,000
– –
PICC.U
767
DELISTED
Pivotal Investment Corporation III Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
PICC.U
$148K ﹤0.01%
15,000
– –
FTAAU
768
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
$102K ﹤0.01%
10,000
– –
ASPCU
769
DELISTED
Alpha Capital Acquisition Co Unit
ASPCU
$101K ﹤0.01%
10,000
– –
GMBTU
770
DELISTED
Pivotal Holdings Corp Unit
GMBTU
$101K ﹤0.01%
10,000
– –
APGB.U
771
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
$100K ﹤0.01%
10,000
– –
PRDS
772
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$100K ﹤0.01%
10,000
– –
CLIM.U
773
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CLIM.U
$100K ﹤0.01%
10,000
– –
ATAQ.U
774
DELISTED
Altimar Acquisition Corp III Units
ATAQ.U
$100K ﹤0.01%
10,000
– –
SLACU
775
DELISTED
Social Leverage Acquisition Corp I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
SLACU
$99K ﹤0.01%
10,000
– –
29 30
31
32 33

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.